UK clears AstraZeneca-Alexion deal

Wednesday, 14. July 2021 08:35

AstraZeneca plc announced on Wednesday that its acquisition of Alexion Pharmaceuticals Inc. has been cleared by the United Kingdom Competition and Markets Authority (CMA), meaning that the deal is expected to be finalized on July 21.

"We look forward to the imminent closing of the transaction so that we may pursue our shared ambition to bring more innovative medicines to patients worldwide and begin AstraZeneca's next chapter of growth," the company's Executive Director and Chief Financial Officer Marc Dunoyer commented.

The British competition regulator has been investigating the $39 billion deal since late May.

Related Links: AstraZeneca plcAlexion Pharmaceuticals Inc.
Breaking the News / MS